Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Medication Use Evaluation of Dronedarone in Comparison to Amiodarone

Amiodarone is the most effective rhythm-control for atrial fibrillation, but produces serious potential side effects. Dronedarone was designed to eliminate amiodarone toxicities, but increased the risk of mortality in clinical trials. This medication use evaluation compares one year of dronedarone u...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Adam Corey, Nita Johnston
Natura:	Articolo
Lingua:	English
Pubblicazione:	University of Minnesota Libraries Publishing 2016-12-01
Serie:	INNOVATIONS in Pharmacy
Soggetti:	Dronedarone, Amiodarone, Medication Use Evaluation, Atrial Fibrillation
Accesso online:	https://pubs.lib.umn.edu/index.php/innovations/article/view/480

Documenti analoghi

Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation
di: Li Y, et al.
Pubblicazione: (2023-12-01)

Cost-Effectiveness of Dronedarone and Amiodarone for the Treatment of Chinese Patients With Atrial Fibrillation
di: Mengran Zhang, et al.
Pubblicazione: (2021-08-01)

Dronedarone and Amiodarone Induce Dyslipidemia and Thyroid Dysfunction in Rats
di: Li-Qin Jiang, et al.
Pubblicazione: (2016-05-01)

Managing atrial fibrillation in the elderly: critical appraisal of dronedarone
di: Trigo P, et al.
Pubblicazione: (2011-12-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
di: M. Yu. Gilyarov, et al.
Pubblicazione: (2010-12-01)

Dronedarone for the management of atrial fibrillation
di: Swiss Medical Weekly
Pubblicazione: (2011-02-01)

Comparative effects of amiodarone and dronedarone treatments on cardiac function in a rabbit model
di: Worakan Boonhoh, et al.
Pubblicazione: (2019-02-01)

Adverse drug reaction signals mining comparison of amiodarone and dronedarone: a pharmacovigilance study based on FAERS
di: Ye Xu, et al.
Pubblicazione: (2024-10-01)

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics
di: Ying Zhang, et al.
Pubblicazione: (2021-08-01)

Impact of dronedarone in atrial fibrillation and flutter on stroke reduction
di: Christine Benn Christiansen, et al.
Pubblicazione: (2010-03-01)

THE USE OF AMIODARONE IN CLINICAL PRACTICE: THE PROBLEM OF SIDE EFFECTS
di: O. V. Gaisenok
Pubblicazione: (2016-01-01)

Marked prolongation of QRS duration after initiation of dronedarone therapy
di: Conrad Genz, et al.
Pubblicazione: (2014-08-01)

Bioavailability of dronedarone tablets administered with or without food in healthy participants
di: Gerald V. Naccarelli, et al.
Pubblicazione: (2024-09-01)

Analysis of a Serious Adverse Reaction of Pulmonary Fibrosis Caused by Dronedarone
di: Yuyan Chen, PM, et al.
Pubblicazione: (2024-01-01)

Dronedarone for Recurrent Ventricular Tachycardia: A Real Alternative?
di: Victor Exposito, MD, et al.
Pubblicazione: (2012-03-01)

Medical conversion of heart rhythm with amiodarone in patients with atrial fibrillation
di: A. G. Pronin, et al.
Pubblicazione: (2020-12-01)

CARDIAC ARRHYTHMIAS IN MEDICAL PRACTICE: CLINICAL CASE OF AMIODARONE-INDUCED THYROTOXICOSIS TYPE 2 AS A CAUSE OF RECURRENT ATRIAL FIBRILLATION
di: O. V. Gaisenok
Pubblicazione: (2016-01-01)

Efficacy and speed of conversion of recent onset atrial fibrillation using oral propafenone versus parenteral amiodarone: A randomized controlled comparative study
di: Hesham S. Taha, et al.
Pubblicazione: (2022-05-01)

Dronedarone-induced photoallergic reaction
di: Levy Amar, PhD, et al.
Pubblicazione: (2020-12-01)

Evaluation of the Prophylactic Effect of Amiodarone in Reducing the Incidence of Post-CABG Atrial Fibrillation
di: Niloofar Dadashpour, et al.
Pubblicazione: (2015-06-01)

NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS
di: S. Yu. Martsevich, et al.
Pubblicazione: (2016-01-01)

Electrophysiological and therapeutic effects of amiodarone in patients with preexcited atrial fibrillation
di: Abolfath Alizadeh, et al.
Pubblicazione: (2022-01-01)

Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
di: K. G. Adamyan, et al.
Pubblicazione: (2015-11-01)

Amiodarone-Induced Pulmonary Toxicity in a Patient With Paroxysmal Atrial Fibrillation and Recurrence of Pulmonary Toxicity
di: Nuri Köse, et al.
Pubblicazione: (2022-01-01)

Amiodarone treatment investigation on the correlation between the drug sensitivity for paroxysmal atrial fibrillation and gene polymorphism
di: Shuxin Hou, et al.
Pubblicazione: (2016-01-01)

Does prophylactic low-dose amiodarone decrease the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery? A randomized controlled trial
di: Mohamed Ali Ahmed, et al.
Pubblicazione: (2022-09-01)

Transient Bradyarrhythmia A Sole Presentation of Amiodarone-Induced Hypothyroidism
di: Gautam Jesrani, et al.
Pubblicazione: (2021-04-01)

Amiodarone pulmonary toxicity: Case report
di: Vasić Nada, et al.
Pubblicazione: (2014-01-01)

Rhythm and rate control effects of intravenous amiodarone for atrial fibrillation complicated by acutely decompensated heart failure
di: Daisuke Horiuchi, MD, et al.
Pubblicazione: (2014-06-01)

SIDE EFFECTS OF PROLONGED ANTIARRHYTHMIC THERAPY WITH AMIODARONE
di: N P Dorofeeva, et al.
Pubblicazione: (2017-03-01)

Late-onset thyrotoxicosis after the cessation of amiodarone
di: Melissa E. Middeldorp, et al.
Pubblicazione: (2020-11-01)

Evaluation of Amiodarone Administration in Patients with New-Onset Atrial Fibrillation in Septic Shock
di: Andreea Oprea, et al.
Pubblicazione: (2024-09-01)

SAFETY OF AMIODARONE USAGE IN PATIENTS WITH WOLFF-PARKINSON-WHITE SYNDROME AND ATRIAL FIBRILLATION
di: D. A. Kuzhel, et al.
Pubblicazione: (2016-01-01)

Case Report: Amiodarone-induced multi-organ toxicity
di: Jingrui Yan, et al.
Pubblicazione: (2024-07-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
di: V. A. Sulimov, et al.
Pubblicazione: (2016-01-01)

Cardiomyocyte-Targeting Peptide to Deliver Amiodarone
di: Maliha Zahid, et al.
Pubblicazione: (2023-08-01)

Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study
di: Kuan-Cheng Lai, et al.
Pubblicazione: (2018-05-01)

A case of probable Amiodarone-induced pancreatitis in the treatment of atrial fibrillation: a literature review and case report
di: Christopher J. Mercogliano, et al.
Pubblicazione: (2017-11-01)

The incidence of phlebitis development of high concentration of continuous amiodarone infusion with in-line filter compared to the low concentration without in-line filter: a retrospective propensity score-matched analysis
di: Sirichai Cheewatanakornkul, et al.
Pubblicazione: (2022-08-01)

Local Use of Hydrogel with Amiodarone in Cardiac Surgery: Experiment and Translation to the Clinic
di: Vladimir Shvartz, et al.
Pubblicazione: (2021-03-01)